Recent results in relaps prevention of alcoholism with Disulfiram;Aktueller stand der pharmakotherapeutischen rückfallprophylaxe mit disulfiram

Neuropsychiatrie

Volumn 22, Issue 4, 2008, Pages 243-251

  Mutschler, Jochen ^a   Diehl, Alexander ^a   Vollmert, Christian ^a   Herre, Hans ^a   Mann, Karl ^a   Kiefer, Falk ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

Addiction; Alcohol; Craving; Disulfiram; Pharmacotherapy

Indexed keywords

ACAMPROSATE; ALCOHOL; AMITRIPTYLINE; ASCORBIC ACID; BENZODIAZEPINE; CALCIUM CARBIMIDE; CEFAMANDOLE; CEFOTAXIME; CHLORDIAZEPOXIDE; CHLORPROPAMIDE; CYTOCHROME P450 2A6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; DIAZEPAM; DISULFIRAM; ERYTHROMYCIN; ISONIAZID; METRONIDAZOLE; NALTREXONE; PHENYTOIN; PLACEBO; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; THEOPHYLLINE; WARFARIN;

ALCOHOLISM; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DEPRESSION; DRUG ALCOHOL INTERACTION; DRUG DOSE COMPARISON; DRUG MECHANISM; DRUG METABOLISM; ESOPHAGUS DISEASE; GERMANY; HUMAN; MONOTHERAPY; PATIENT COMPLIANCE; POLYNEUROPATHY; POSTTRAUMATIC STRESS DISORDER; PSYCHOSIS; RELAPSE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SEXUAL DYSFUNCTION;

EID: 58149349795     PISSN: 09486259     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Bühringer G, Bergmann E, Bloomfield K, Funk W, Junge B, Kraus L, Merfert-Diete C, Rumpf HJ, Simon R, Töppich J, Augustin R (2000) Alkoholkonsum und alkoholbezogene Störungen in Deutschland, Nomos, Baden Baden
2. Donovan D, Mattson ME, Cisler RA. Longabaugh R, Zweben A (2005) Quality of life as an outcome measure in alcoholism treatment research. J Stud Alcohol Suppl.:119-139
3. Weiss F and Porrino LJ (2002) Behavioral neurobiology of alcohol addiction: recent advances and challenges. J Neurosci 22:3332-3337
4. Datenlieferungen nach § 300 SGB V, Wissenschaftliches Institut der AOK WIdO (2007)
5. Johansson B (1992) A review of the pharmacokinetics and pharmacodynamics of disulfiram and its metabolites. Acta Psychiatr Scand Suppl 369:15-26
6. Poikolainen K (2004) The disulfiram-ethanol reaction (DER) experience. Addiction 99:26-28
7. Poulsen H.E. Disulfiram therapy - adverse drug reactions and interactions. Loft S, Andersen J.R., Andersen M., editors. Acta Psychiatr Scand 1992; 86: 59-66
8. Guild J and Epstein NB (1951) Psychosis during the treatment of alcoholism with tetraethylthiuram disulfide. Q J Stud Alcohol 12:360-366
9. Williams EE (1937) Effects of alcohol on workers with carbon disulfide. JAMA 109: 1472-1473
10. Hughes JC and Cook CC (1997) The efficacy of disulfiram: a review of outcome studies. Addiction 92:381-395
11. Fuller RK, Branchey L, Brightwell DR, Derman RM, Emrick CD, Iber FL, James KE, Lacoursiere RB, Lee KK, Lowenstam I, . (1986) Disulfiram treatment of alcoholism. A Veterans Administration cooperative study. JAMA 19;256:1449-1455
12. Chick J, Gough K, Falkowski W, Kershaw P, Hore B, Mehta B, Ritson B, Ropner R, Torley D (1992) Disulfiram treatment of alcoholism. Br J Psychiatry 161:84-9.:84-89
13. De Sousa A and De Sousa A (2005) An open randomized study comparing disulfiram and acamprosate in the treatment of alcohol dependence. Alcohol Alcohol 40:545-548
14. De Sousa A and De Sousa A (2004) A one-year pragmatic trial of naltrexone vs disulfiram in the treatment of alcohol dependence. Alcohol Alcohol 39:528-531
15. Krampe H, Stawicki S, Wagner T, Bartels C, Aust C, Ruther E, Poser W, Ehrenreich H (2006) Follow-up of 180 alcoholic patients for up to 7 years after outpatient treatment: impact of alcohol deterrents on outcome. Alcohol Clin Exp Res 30:86-95
16. Wagner T, Krampe H, Stawicki S, Reinhold J, Jahn H, Mahlke K, Barth U, Sieg S, Maul O, Galwas C, Aust C, Kroner-Herwig B, Brunner E, Poser W, Henn F, Ruther E, Ehrenreich H (2004) Substantial decrease of psychiatric comorbidity in chronic alcoholics upon integrated outpatient treatment - results of a prospective study. J Psychiatr Res 38:619-635
17. Mann K (2004) Pharmacotherapy of alcohol dependence: a review of the clinical data. CNS Drugs 18:485-504
18. Mann K, Lehert P, Morgan MY (2004) The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis. Alcohol Clin Exp Res 28:51-63
19. Kiefer F, Jahn H, Tarnaske T, Helwig H, Briken P, Holzbach R, Kampf P, Stracke R, Baehr M, Naber D, Wiedemann K (2003) Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study. Arch Gen Psychiatry 60:92-99
20. Landabaso MA, Iraurgi I, Sanz J, Calle R, Ruiz de Apodaka J, Jimenez-Lerma JM, Gutierrez-Fraile M (1999) Naltrexone in the treatment of alcoholism. Two-year follow up results. Eur J Psychiatry 13:97-105
21. Petrakis IL, Poling J, Levinson C, Nich C, Carroll K, Ralevski E, Rounsaville B (2006) Naltrexone and disulfiram in patients with alcohol dependence and comorbid post-traumatic stress disorder. Biol Psychiatry 60:777-783
22. Petrakis IL, Poling J, Levinson C, Nich C, Carroll K, Rounsaville B (2005) Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders. Biol Psychiatry 57:1128-1137
23. Besson J, Aeby F, Kasas A, Lehert P, Potgieter A (1998) Combined efficacy of acamprosate and disulfiram in the treatment of alcoholism: a controlled study. Alcohol Clin Exp Res 22:573-579
24. Finney JW and Monahan SC (1996) The cost-effectiveness of treatment for alcoholism: a second approximation. J Stud Alcohol 57:229-243
25. Miller WR and Wilbourne PL (2002) Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders. Addiction 97:265-277
26. Kellam AM and Wesolkowski JM (1968) Disulfiram implantation for alcoholism. Lancet 1:925-926
27. Wilson A, Davidson WJ, Blanchard R, White J (1978) Disulfiram implantation. A placebo-controlled trial with two-year follow-up. J Stud Alcohol 39:809-81
28. Matching Alcoholism Treatments to Client Heterogeneity: Project MATCH (1997) posttreatment drinking outcomes. J Stud Alcohol 58:7-29
29. Moos RH, Finney JW, Ouimette PC, Suchinsky RT (1999) A comparative evaluation of substance abuse treatment: I. Treatment orientation, amount of care, and 1-year outcomes. Alcohol Clin Exp Res 23:529-536
30. Berglund M (2005) A better widget? Three lessons for improving addiction treatment from a meta-analytical study. Addiction 100:742-750
31. Besson J, Aeby F, Kasas A, Lehert P, Potgieter A (1998) Combined efficacy of acamprosate and disulfiram in the treatment of alcoholism: a controlled study. Alcohol Clin Exp Res 22:573-579
32. Ehrenreich H and Krampe H (2004) Does disulfiram have a role in alcoholism treatment today? Not to forget about disulfiram's psychological effects. Addiction 99:26-27
33. Fuller RK and Gordis E (2004) Does disulfiram have a role in alcoholism treatment today? Addiction 99:21-24
34. Suh JJ, Pettinati HM, Kampman KM, O'Brien CP (2006) The status of disulfiram: a half of a century later. J Clin Psychopharmacol 26:290-302
35. Carroll KM, Fenton LR, Ball SA, Nich C, Frankforter TL, Shi J, Rounsaville BJ (2004) Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial. Arch Gen Psychiatry 61:264-272
36. Fritze J (2005) Psychopharmaka-Verordnungen: Ergebnisse und Kommentare zum Arzneiverordnungsreport 2004. Psychoneuro 31:46-52
37. Kiefer F, Jahn H, Holzbach R, Briken P, Stracke R, Wiedemann K (2003) Die NACALM-Studie: Wirksamkeit, Verträglichkeit, Outcome. Sucht 49:342-35